Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Product type
Topic
- Committees and advisory bodies (384)
- Scheduling (national classification system) (166)
- Safety monitoring and information (27)
- Advertising (25)
- COVID-19 (11)
- Manufacturing (11)
- Clinical trials (6)
- Medicinal cannabis hub (6)
- Sunscreens (5)
- Compliance and enforcement (4)
- Fees and payments (4)
- Shortages and supply disruptions (4)
- Legislation (3)
- Import and export (2)
- Breast implant hub (1)
- Cosmetics (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Prescription opioids hub (1)
- Unique Device Identification (UDI) hub (1)
Search
18 result(s) found, displaying 1 to 18
-
Scheduling decisions (final)This web publication constitutes a notice for the purposes of regulations 42ZCZS and 42ZCZX of the Therapeutic Goods Regulations 1990 (the Regulations).
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Scheduling decisions (final)This web publication constitutes a notice for the purposes of regulations 42ZCZS and 42ZCZX of the Therapeutic Goods Regulations 1990 (the Regulations).
-
Corporate reportsFind out about the seasonal influenza vaccines available for the 2024 southern hemisphere season.
-
Corporate reportsThe TGA Pharmacovigilance Inspection Program (PVIP) metrics report for 2021 is now available.
-
-
TGA laboratory testing reportsThe TGA has released a report on the laboratory testing of listed medicines for Aconitum alkaloid content.
-
Corporate reportsThe PVIP aims to strengthen and broaden the TGA's post-market monitoring activities and protect public health
-
-
Corporate reportsResults of communication developmental research undertaken to inform consumer and health professional communication activities for the opioid regulatory reforms.
-
Corporate reportsRead our clinician information sheet on opioid analgesic tapering: summary.
-
TGA laboratory testing reportsTGA Laboratories has released a new report describing our assessment of the 2020 seasonal flu vaccine
-
TGA Laboratories testing report: Microbiological testing of medicines containing Green-lipped Mussel
TGA laboratory testing reportsTGA Laboratories Branch has released a report summarising the microbiological testing of green-lipped mussel products -
Corporate reportsIn 2019, the TGA conducted 10 pharmacovigilance inspections of Australian medicine sponsors
-
TGA laboratory testing reportsUpdates have been made to the previously published report related to the testing of HPV vaccines available in Australia
-
TGA laboratory testing reportsThe TGA Laboratories has published a detailed report related to the testing of measles vaccines available in Australia
-
Corporate reportsPost-market vigilance statistics for 2017